A retrospective analysis compares trabectedin and gemcitabine in advanced leiomyosarcoma, suggesting treatment implications.
No takes yet. Share an insight, caveat, or question.
Garofalo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: